196 related articles for article (PubMed ID: 15660655)
1. Cluster designation 5 staining of normal and non-lymphoid neoplastic skin.
Bogner PN; Su LD; Fullen DR
J Cutan Pathol; 2005 Jan; 32(1):50-4. PubMed ID: 15660655
[TBL] [Abstract][Full Text] [Related]
2. The expression of CD23 in cutaneous non-lymphoid neoplasms.
Carvalho J; Fullen D; Lowe L; Su L; Ma L
J Cutan Pathol; 2007 Sep; 34(9):693-8. PubMed ID: 17696916
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytokeratin subtypes in intraepidermal malignancies: a guide for differentiation.
Aslan F; Demirkesen C; Cağatay P; Tüzüner N
J Cutan Pathol; 2006 Aug; 33(8):531-8. PubMed ID: 16919026
[TBL] [Abstract][Full Text] [Related]
4. Ber-EP4 enhances the differential diagnostic accuracy of cytokeratin 7 in pagetoid cutaneous neoplasms.
Sellheyer K; Krahl D
J Cutan Pathol; 2008 Apr; 35(4):366-72. PubMed ID: 18333896
[TBL] [Abstract][Full Text] [Related]
5. [Bowen's disease and Paget's disease].
Hoede N
Med Welt; 1981 May; 32(18):689-90. PubMed ID: 6262596
[No Abstract] [Full Text] [Related]
6. Apocrine gland carcinoma of the mammary skin concomitant with pagetoid phenomenon.
Usui K; Ochiai T; Abe I; Nishio H; Togo K; Yamagata M
J Dermatol; 2010 Apr; 37(4):350-4. PubMed ID: 20507405
[TBL] [Abstract][Full Text] [Related]
7. The differential diagnosis of pagetoid cells in the epidermis.
Kohler S; Rouse RV; Smoller BR
Mod Pathol; 1998 Jan; 11(1):79-92. PubMed ID: 9556428
[TBL] [Abstract][Full Text] [Related]
8. Bowen's disease, Paget's disease, and malignant melanoma in situ.
Rosen L; Amazon K; Frank B
South Med J; 1986 Apr; 79(4):410-3. PubMed ID: 2422766
[TBL] [Abstract][Full Text] [Related]
9. Immunohistology is valuable in distinguishing between Paget's disease, Bowen's disease and superficial spreading malignant melanoma.
Reed W; Oppedal BR; Eeg Larsen T
Histopathology; 1990 Jun; 16(6):583-8. PubMed ID: 1695889
[TBL] [Abstract][Full Text] [Related]
10. Perianal Paget disease. Histochemical differentiation utilizing the borohydride-KOH-PAS reaction.
Wood WS; Culling CF
Arch Pathol; 1975 Aug; 99(8):442-5. PubMed ID: 50063
[TBL] [Abstract][Full Text] [Related]
11. Expression of Bcl-x in normal skin and benign cutaneous adnexal tumors.
Thamboo TP; Tan LH; Tan SY
J Cutan Pathol; 2006 Jan; 33(1):27-32. PubMed ID: 16441408
[TBL] [Abstract][Full Text] [Related]
12. Pagetoid dyskeratosis of the nipple epidermis: an incidental finding mimicking Paget's disease of the nipple.
Garijo MF; Val D; Val-Bernal JF
APMIS; 2008 Feb; 116(2):139-46. PubMed ID: 18321365
[TBL] [Abstract][Full Text] [Related]
13. Pigmented mammary Paget disease: dermoscopic, in vivo reflectance-mode confocal microscopic, and immunohistochemical study of a case.
Longo C; Fantini F; Cesinaro AM; Bassoli S; Seidenari S; Pellacani G
Arch Dermatol; 2007 Jun; 143(6):752-4. PubMed ID: 17576941
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical distinction of Paget's disease from Bowen's disease and superficial spreading melanoma with the use of monoclonal cytokeratin antibodies.
Shah KD; Tabibzadeh SS; Gerber MA
Am J Clin Pathol; 1987 Dec; 88(6):689-95. PubMed ID: 2446491
[TBL] [Abstract][Full Text] [Related]
15. Potential utility of CD5 immunohistochemical staining in the diagnosis of muscle tumors.
McNab PM; DeMers NM; Schlauder S; Morgan M; Nasir A; Coppola D; Bui MM
Ann Clin Lab Sci; 2009; 39(2):108-13. PubMed ID: 19429795
[TBL] [Abstract][Full Text] [Related]
16. Mammary Paget's disease and associated carcinoma. An immunohistochemical study.
Cohen C; Guarner J; DeRose PB
Arch Pathol Lab Med; 1993 Mar; 117(3):291-4. PubMed ID: 7680194
[TBL] [Abstract][Full Text] [Related]
17. Mammary and extramammary Paget's disease.
Kanitakis J
J Eur Acad Dermatol Venereol; 2007 May; 21(5):581-90. PubMed ID: 17447970
[TBL] [Abstract][Full Text] [Related]
18. Pagetoid variant of actinic keratosis with or without squamous cell carcinoma of sun-exposed skin: a lesion simulating extramammary Paget's disease.
Mai KT; Alhalouly T; Landry D; Stinson WA; Perkins DG; Yazdi HM
Histopathology; 2002 Oct; 41(4):331-6. PubMed ID: 12383215
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
Krahl D; Sellheyer K
J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry for CD117 (KIT) is effective in distinguishing cutaneous adnexal tumors with apocrine/eccrine or sebaceous differentiation from other epithelial tumors of the skin.
Goto K
J Cutan Pathol; 2015 Jul; 42(7):480-8. PubMed ID: 25864700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
